Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

https://doi.org/10.14412/2074-2711-2026-1-70-75

Abstract

   Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic hereditary disease of the small vessels of the brain caused by mutations in the NOTCH3 gene. We present the case of a 46-year-old patient whose CADASIL diagnosis was confirmed by genetic testing. In March 2023, the patient suffered an acute cerebrovascular accident with an infarction in the right midbrain tegmentum, developing diplopia when looking to the left, ataxia, followed by regression of symptoms. In June 2024, the patient's behaviour changed and weakness appeared in his right arm. An MRI revealed a subacute infarction in the basal structures of the left hemisphere of the brain, diffuse changes in the white matter of the temporal and frontal lobes, multiple small deep (lacunar) infarcts in the basal structures of both hemispheres of the cerebrum, the left thalamus, periventricular white matter, and corpus callosum. Genetic testing revealed a heterozygous mutation in the NOTCH3 gene – p.R169C (g528933696). A distinctive feature of clinical observation is the absence of migraine in patients with genetically confirmed CADASIL syndrome, as well as clinically pronounced cognitive and neuropsychological disorders.

About the Authors

M. Yu. Maksimova
Russian Center of Neurology and Neuroscience
Russian Federation

Marina Yurievna Maksimova

125367; 80, Volokolamskoe Sh.; Moscow


Competing Interests:

There are no conflicts of interest



A. S. Airapetova
Russian Center of Neurology and Neuroscience
Russian Federation

125367; 80, Volokolamskoe Sh.; Moscow


Competing Interests:

There are no conflicts of interest



References

1. Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol. 2009;8(7):643-53. doi: 10.1016/S1474-4422(09)70127-9

2. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707-10. doi: 10.1038/383707a0

3. Monet-Lepretre M, Haddad I, Baron-Menguy C, et al. Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. Brain. 2013;136(Pt 6):1830-45. doi: 10.1093/brain/awt092

4. Rutten JW, Haan J, Terwindt GM, et al. Interpretation of NOTCH3 mutations in the diagnosis of CADASIL. Expert Rev Mol Diagn. 2014;14(5):593-603. doi: 10.1586/14737159.2014.922880

5. Dupre N, Gueniot F, Domenga-Denier V, et al. Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL. J Clin Invest. 2024;134(8):e175789. doi: 10.1172/JCI175789

6. Neves KB, Morris HE, Alves-Lopes R, et al. Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway. Clin Sci (Lond). 2021;135(6):753-73. doi: 10.1042/CS20201412

7. Yuan L, Chen X, Jankovic J, Deng H. CADASIL: A NOTCH3-associated cerebral small vessel disease. J Adv Res. 2024;66:223-35. doi: 10.1016/j.jare.2024.01.001

8. Sukhonpanich N, Koohi F, Jolly AA, Markus HS. Changes in the prognosis of CADASIL over time: a 23-year study in 555 individuals. J Neurol Neurosurg Psychiatry. 2024:jnnp-2024-334823. doi: 10.1136/jnnp-2024-334823

9. Meschia JF, Worrall BB, Elahi FM, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Hypertension. Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association. Stroke. 2023;54(10):e452-e464. doi: 10.1161/STR.0000000000000444

10. Nakamura T, Watanabe H, Hirayama M, et al. CADASIL with NOTCH3 S180C presenting anticipation of onset age and hallucinations. J Neurol Sci. 2005;238(1-2):87-91. doi: 10.1016/j.jns.2005.07.001

11. Pescini F, Nannucci S, Bertaccini B, et al. The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke. 2012;43(11):2871-6. doi: 10.1161/STROKEAHA.112.665927

12. Rutten JW, Van Eijsden BJ, Duering M, et al. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant. Genet Med. 2019;21(3):676-82. doi: 10.1038/s41436-018-0088-3

13. Yamamoto Y, Liao YC, Lee YC, et al. Update on the epidemiology, pathogenesis, and biomarkers of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Clin Neurol. 2023;19:12-27. doi: 10.3988/jcn.2023.19.1.12

14. Locatelli M, Padovani A, Pezzini A. Pathophysiological mechanisms and potential therapeutic targets in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Front Pharmacol. 2020;11:321. doi: 10.3389/fphar.2020.00321

15. Santa Y, Uyama E, Chui DH, et al. Genetic, clinical and pathological studies of CADASIL in Japan: a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis. J Neurol Sci. 2003;212:79-84. doi: 10.1016/s0022-510x(03)00109-6

16. Wesolowski W, Dziewulska D, Koziarska M, Izycka-Swieszewska E. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) – literature review apropos an autopsy case. Pol J Pathol. 2015;66:323-9. doi: 10.5114/pjp.2015.54966

17. Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology. 2002;59(8):1134-8. doi: 10.1212/wnl.59.8.1134

18. Guey S, Mawet J, Herve D, et al. Prevalence and characteristics of migraine in CADASIL. Cephalalgia. 2016;36(11):1038-47. doi: 10.1177/0333102415620909

19. Tan RY, Markus HS. CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships. PLoS One. 2016;11(6):e0157613. doi: 10.1371/journal.pone.0157613

20. Eikermann-Haerter K. Spreading depolarization may link migraine and stroke. Headache. 2014;54(7):1146-57. doi: 10.1111/head.12386

21. Brennan KC, Beltran-Parrazal L, Lopez-Valdes HE, et al. Distinct vascular conduction with cortical spreading depression. J Neurophysiol. 2007;97:4143-51. doi: 10.1152/jn.00028.2007

22. Liu X, Sheng R, Qin Z. The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin. 2009;30:1071-80. doi: 10.1038/aps.2009.105

23. Goldstein ED, Gopal N, Badi MK, et al. CGRP, Migraine, and Brain MRI in CADASIL: A Pilot Study. Neurologist. 2023;28(4):231-6. doi: 10.1097/NRL.0000000000000478

24. Mizuno T, Mizuta I, Watanabe-Hosomi A, et al. Clinical and genetic aspects of CADASIL. Front Aging Neurosci. 2020;12:91. doi: 10.3389/fnagi.2020.00091

25. Peters N, Opherk C, Danek A, et al. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162(11):2078-85. doi: 10.1176/appi.ajp.162.11.2078

26. Jolly AA, Nannoni S, Edwards H, et al. Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL. Neurology. 2022;99(5):e453-e461. doi: 10.1212/WNL.0000000000200607

27. Gorelick PB, Sorond FA. Advancing our knowledge about cerebral small vessel diseases. Lancet Neurol. 2023;22:972-3. doi: 10.1016/S1474-4422(23)00318-6

28. Zhang R, Chen CH, Tezenas Du Montcel S, et al. The CADA-MRIT: an MRI inventory tool for evaluating cerebral lesions in CADASIL across cohorts. Neurology. 2023;101:e1665-77.

29. Assareh A, Mather KA, Schofield PR, et al. The genetics of white matter lesions. CNS Neurosci Ther. 2011;17:525-40. doi: 10.1111/j.1755-5949.2010.00181.x

30. Olszewska DA, Rawal S, Fearon C, et al. Neuroimaging pearls from the MDS Congress Video Challenge. Part 1: genetic disorders. Mov Disord Clin Pract. 2022;9:297-310. doi: 10.1002/mdc3.13412

31. Van Den Boom R, Lesnik Oberstein SA, van Duinen SG, et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology. 2002 Sep;224(3):791-6. doi: 10.1148/radiol.2243011123

32. Nannucci S, Rinnoci V, Pracucci G, et al. Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients. PLoS One. 2018;13. doi: 10.1371/journal.pone.0190878

33. Sukhonpanich N, Markus HS. Prevalence, clinical characteristics, and risk factors of intracerebral haemorrhage in CADASIL : a case series and systematic review. J Neurol. 2024;271(5):2423-33. doi: 10.1007/s00415-023-12177-0

34. Illarioshkin SN, Slominsky PA, Shadrina MI, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): first description of a Russian family with the identified mutation in the Notch3 gene. Annals of Clinical and Experimental Neurology. 2008;2(2):45-50 (In Russ.). doi: 10.1590/0004-282X20150113

35. Moroz AA, Abramycheva NYu, Stepanova MS, et al. Differential diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):75-80 (In Russ.). doi: 10.17116/jnevro20171174175-80

36. Cherebillo CC, Nazarov VD, Lapin CV, et al. Magnetic-resonance imaging semiology of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in subjects from Russian Federation. Russian Neurological Journal. 2023;28(1):13-24 (In Russ.). doi: 10.30629/2658-7947-2023-28-1-13-24


Review

For citations:


Maksimova MY, Airapetova AS. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2026;18(1):70-75. (In Russ.) https://doi.org/10.14412/2074-2711-2026-1-70-75

Views: 408

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)